Cargando…

Is Curfew Effective in Limiting SARS-CoV-2 Progression? An Evaluation in France Based on Epidemiokinetic Analyses

BACKGROUND: Since late summer 2020, the French authorities implemented a curfew/lightened lockdown-alternating strategy instead of strict lockdown, to improve acceptability and limit socioeconomic consequences. However, data on curfew-related efficacy to control the epidemic are scarce. OBJECTIVE: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Mégarbane, Bruno, Bourasset, Fanchon, Scherrmann, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205314/
https://www.ncbi.nlm.nih.gov/pubmed/34131877
http://dx.doi.org/10.1007/s11606-021-06953-9
_version_ 1783708484064247808
author Mégarbane, Bruno
Bourasset, Fanchon
Scherrmann, Jean-Michel
author_facet Mégarbane, Bruno
Bourasset, Fanchon
Scherrmann, Jean-Michel
author_sort Mégarbane, Bruno
collection PubMed
description BACKGROUND: Since late summer 2020, the French authorities implemented a curfew/lightened lockdown-alternating strategy instead of strict lockdown, to improve acceptability and limit socioeconomic consequences. However, data on curfew-related efficacy to control the epidemic are scarce. OBJECTIVE: To investigate the effects on COVID-19 spread in France of curfew combined to local and/or nationwide restrictions from late summer 2020 to mid-February 2021. DESIGN: We conducted a comparative evaluation using a susceptible-infected-recovered (SIR)–based model completed with epidemiokinetic tools. MAIN MEASURES: We analyzed the time-course of epidemic progression rate under curfew in French Guyana and five metropolitan regions where additional restrictions were implemented at different times. Using linear regressions of the decay/increase rates in daily contaminations, we calculated the epidemic regression half-lives (t(1/2β)) for each identified period. KEY RESULTS: In French Guyana, two decay periods with rapid regression (t(1/2β) of ~10 days) were observed under curfew, with slowing (t(1/2β) of ~43 days) when curfew was lightened. During the 2-week pre-lockdown curfew (2020/10/17–2020/11/02) in Provence-Alpes-Côte-d’Azur, Auvergne-Rhône-Alpes, and Ile-de-France, the epidemic progression was unchanged. During the post-lockdown curfew (2020/12/15–2020/02/14), the epidemic slowly regressed in Grand-Est (t(1/2β) of ~37 days), whereas its progression rate plateaued in Auvergne-Rhône-Alpes and increased immediately in Provence-Alpes-Côte-d’Azur, Ile-de-France, and Nouvelle-Aquitaine, whatever the curfew starting time was (06:00 or 08:00 pm). Interestingly, a delayed slow decay (17 days < t(1/2β) < 64 days) occurred under curfew in all regions except Ile-de-France. CONCLUSIONS: Curfew allowed the temporary control of SARS-CoV-2 epidemic, however variably in the French regions, without preventing lockdown necessity. To accelerate the epidemic regression such as observed in French Guyana, curfew should be implemented timely with additional restrictions.
format Online
Article
Text
id pubmed-8205314
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82053142021-06-16 Is Curfew Effective in Limiting SARS-CoV-2 Progression? An Evaluation in France Based on Epidemiokinetic Analyses Mégarbane, Bruno Bourasset, Fanchon Scherrmann, Jean-Michel J Gen Intern Med Original Research BACKGROUND: Since late summer 2020, the French authorities implemented a curfew/lightened lockdown-alternating strategy instead of strict lockdown, to improve acceptability and limit socioeconomic consequences. However, data on curfew-related efficacy to control the epidemic are scarce. OBJECTIVE: To investigate the effects on COVID-19 spread in France of curfew combined to local and/or nationwide restrictions from late summer 2020 to mid-February 2021. DESIGN: We conducted a comparative evaluation using a susceptible-infected-recovered (SIR)–based model completed with epidemiokinetic tools. MAIN MEASURES: We analyzed the time-course of epidemic progression rate under curfew in French Guyana and five metropolitan regions where additional restrictions were implemented at different times. Using linear regressions of the decay/increase rates in daily contaminations, we calculated the epidemic regression half-lives (t(1/2β)) for each identified period. KEY RESULTS: In French Guyana, two decay periods with rapid regression (t(1/2β) of ~10 days) were observed under curfew, with slowing (t(1/2β) of ~43 days) when curfew was lightened. During the 2-week pre-lockdown curfew (2020/10/17–2020/11/02) in Provence-Alpes-Côte-d’Azur, Auvergne-Rhône-Alpes, and Ile-de-France, the epidemic progression was unchanged. During the post-lockdown curfew (2020/12/15–2020/02/14), the epidemic slowly regressed in Grand-Est (t(1/2β) of ~37 days), whereas its progression rate plateaued in Auvergne-Rhône-Alpes and increased immediately in Provence-Alpes-Côte-d’Azur, Ile-de-France, and Nouvelle-Aquitaine, whatever the curfew starting time was (06:00 or 08:00 pm). Interestingly, a delayed slow decay (17 days < t(1/2β) < 64 days) occurred under curfew in all regions except Ile-de-France. CONCLUSIONS: Curfew allowed the temporary control of SARS-CoV-2 epidemic, however variably in the French regions, without preventing lockdown necessity. To accelerate the epidemic regression such as observed in French Guyana, curfew should be implemented timely with additional restrictions. Springer International Publishing 2021-06-15 2021-09 /pmc/articles/PMC8205314/ /pubmed/34131877 http://dx.doi.org/10.1007/s11606-021-06953-9 Text en © Society of General Internal Medicine 2021
spellingShingle Original Research
Mégarbane, Bruno
Bourasset, Fanchon
Scherrmann, Jean-Michel
Is Curfew Effective in Limiting SARS-CoV-2 Progression? An Evaluation in France Based on Epidemiokinetic Analyses
title Is Curfew Effective in Limiting SARS-CoV-2 Progression? An Evaluation in France Based on Epidemiokinetic Analyses
title_full Is Curfew Effective in Limiting SARS-CoV-2 Progression? An Evaluation in France Based on Epidemiokinetic Analyses
title_fullStr Is Curfew Effective in Limiting SARS-CoV-2 Progression? An Evaluation in France Based on Epidemiokinetic Analyses
title_full_unstemmed Is Curfew Effective in Limiting SARS-CoV-2 Progression? An Evaluation in France Based on Epidemiokinetic Analyses
title_short Is Curfew Effective in Limiting SARS-CoV-2 Progression? An Evaluation in France Based on Epidemiokinetic Analyses
title_sort is curfew effective in limiting sars-cov-2 progression? an evaluation in france based on epidemiokinetic analyses
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205314/
https://www.ncbi.nlm.nih.gov/pubmed/34131877
http://dx.doi.org/10.1007/s11606-021-06953-9
work_keys_str_mv AT megarbanebruno iscurfeweffectiveinlimitingsarscov2progressionanevaluationinfrancebasedonepidemiokineticanalyses
AT bourassetfanchon iscurfeweffectiveinlimitingsarscov2progressionanevaluationinfrancebasedonepidemiokineticanalyses
AT scherrmannjeanmichel iscurfeweffectiveinlimitingsarscov2progressionanevaluationinfrancebasedonepidemiokineticanalyses